BRPI0900030A2 - compostos de 1h-indol-1-il-uréia, um processo para sua preparação e composições farmacêuticas contendo-os - Google Patents
compostos de 1h-indol-1-il-uréia, um processo para sua preparação e composições farmacêuticas contendo-osInfo
- Publication number
- BRPI0900030A2 BRPI0900030A2 BRPI0900030-5A BRPI0900030A BRPI0900030A2 BR PI0900030 A2 BRPI0900030 A2 BR PI0900030A2 BR PI0900030 A BRPI0900030 A BR PI0900030A BR PI0900030 A2 BRPI0900030 A2 BR PI0900030A2
- Authority
- BR
- Brazil
- Prior art keywords
- linear
- indol
- pharmaceutical compositions
- compositions containing
- branched
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
Abstract
COMPOSTOS DE 1H-INDOL-1-IL-URéIA, UM PROCESSO PARA SUA PREPARAçãO E COMPOSIçõES FARMACêUTICAS CONTENDO-OS. Compostos de fórmula (I): em que: - R~ 1~ e R~ 2~, que podem ser os mesmos ou diferentes, representam um átomo de hidrogênio ou um grupo (C~ 1~-C~ 6~)alquila linear ou ramificado, - R~ 3~ representa um átomo de hidrogênio ou halogênio, um grupo (C~ 1~-C~ 6~)alquila linear ou ramificado, ou um grupo (C~ 1~-C~ 6~)alcóxi linear ou ramificado, - Het representa um grupo piridila, pirimidinila ou piperidila, que são opcionalmente substituidos por um ou mais grupos selecionados de halogênio, (C~ 1~-C~ 6~)alquila linear ou ramificado e (C~ 1~-C~ 6~)alcóxi linear ou ramificado, representa uma ligação simples ou uma ligação dupla, seus enantiómeros e diastereoisómeros, e também sais de adição destes com um ácido ou base farmaceuticamente aceitável. Medicamentos.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0800043A FR2926077A1 (fr) | 2008-01-04 | 2008-01-04 | Nouveaux derives d'1h-indol-1-yl uree, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0900030A2 true BRPI0900030A2 (pt) | 2009-09-15 |
Family
ID=39427563
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0900030-5A BRPI0900030A2 (pt) | 2008-01-04 | 2009-01-02 | compostos de 1h-indol-1-il-uréia, um processo para sua preparação e composições farmacêuticas contendo-os |
Country Status (17)
Country | Link |
---|---|
US (1) | US20090176794A1 (pt) |
EP (1) | EP2078716A1 (pt) |
JP (1) | JP2009196976A (pt) |
KR (1) | KR20090075632A (pt) |
CN (1) | CN101475560A (pt) |
AR (1) | AR070070A1 (pt) |
AU (1) | AU2009200010A1 (pt) |
BR (1) | BRPI0900030A2 (pt) |
CA (1) | CA2648836A1 (pt) |
EA (1) | EA200802427A1 (pt) |
FR (1) | FR2926077A1 (pt) |
MA (1) | MA30619B1 (pt) |
MX (1) | MX2009000254A (pt) |
NZ (1) | NZ573976A (pt) |
SG (1) | SG153774A1 (pt) |
WO (1) | WO2009106753A1 (pt) |
ZA (1) | ZA200810841B (pt) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EA202192084A1 (ru) * | 2019-02-01 | 2021-10-20 | ХОФФМАН ТЕКНОЛОДЖИЗ ЭлЭлСи. | Композиции и способы для лечения связанных с тревожностью нарушений |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3454583A (en) | 1965-07-19 | 1969-07-08 | Us Health Education & Welfare | Synthesis of vincamine |
FR2381048A1 (fr) | 1977-02-22 | 1978-09-15 | Roussel Uclaf | Nouveaux derives de 20,21-dinoreburnamenine, un procede pour leur preparation et leur application comme medicaments |
FR2433528A2 (fr) | 1978-08-16 | 1980-03-14 | Roussel Uclaf | Nouveaux derives de 20,21-dinoreburnamenine, un procede pour leur preparation et leur application comme medicaments |
FR2614022B1 (fr) | 1987-04-15 | 1989-12-01 | Roussel Uclaf | Nouveaux derives 17-aza de 20,21-dinoreburnamenine, leur procede de preparation et les nouveaux intermediaires ainsi obtenus, leur application comme medicaments et ces compositions les renfermant |
WO1993018026A1 (en) * | 1992-03-04 | 1993-09-16 | Beecham Group Plc | Indole ureas as 5-ht1c receptor antogonists |
US5319096A (en) * | 1992-04-03 | 1994-06-07 | Hoechst-Roussel Pharmaceuticals Inc. | (1H-indol-1-yl)-2-(amino) acetamides and related (1H-indol-1-yl)-(aminoalkyl)amides, pharmaceutical composition and use |
FR2713644B1 (fr) | 1993-12-14 | 1996-02-09 | Adir | Nouveaux analogues de l'éburnane, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. |
AUPO390996A0 (en) * | 1996-11-29 | 1996-12-19 | Fujisawa Pharmaceutical Co., Ltd. | Urea derivatives |
FR2888238B1 (fr) * | 2005-07-07 | 2007-09-07 | Servier Lab | Nouveaux derives 1h-indole-pyridinecarboxamides et 1h-indole-piperidinecarboxamide, leur procede de preparation et les compositions pharceumatiques qui les contiennent. |
FR2911143A1 (fr) * | 2007-01-05 | 2008-07-11 | Servier Lab | Utilisation de composes neuroprotecteurs pour l'obtention de medicaments destines au traitement de maladies neurodegeneratives. |
-
2008
- 2008-01-04 FR FR0800043A patent/FR2926077A1/fr active Pending
- 2008-12-18 SG SG200809399-9A patent/SG153774A1/en unknown
- 2008-12-23 ZA ZA200810841A patent/ZA200810841B/en unknown
- 2008-12-24 NZ NZ573976A patent/NZ573976A/en not_active IP Right Cessation
- 2008-12-26 JP JP2008331704A patent/JP2009196976A/ja active Pending
- 2008-12-26 MA MA31520A patent/MA30619B1/fr unknown
- 2008-12-29 EA EA200802427A patent/EA200802427A1/ru unknown
- 2008-12-30 US US12/317,904 patent/US20090176794A1/en not_active Abandoned
- 2008-12-30 CN CNA2008101905458A patent/CN101475560A/zh active Pending
- 2008-12-30 AR ARP080105775A patent/AR070070A1/es unknown
- 2008-12-31 WO PCT/FR2008/001842 patent/WO2009106753A1/fr active Application Filing
- 2008-12-31 CA CA002648836A patent/CA2648836A1/fr not_active Abandoned
- 2008-12-31 EP EP08291259A patent/EP2078716A1/fr not_active Withdrawn
-
2009
- 2009-01-02 BR BRPI0900030-5A patent/BRPI0900030A2/pt not_active IP Right Cessation
- 2009-01-02 KR KR1020090000077A patent/KR20090075632A/ko not_active Application Discontinuation
- 2009-01-02 AU AU2009200010A patent/AU2009200010A1/en not_active Abandoned
- 2009-01-07 MX MX2009000254A patent/MX2009000254A/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AR070070A1 (es) | 2010-03-10 |
WO2009106753A1 (fr) | 2009-09-03 |
CA2648836A1 (fr) | 2009-07-04 |
MX2009000254A (es) | 2009-08-12 |
JP2009196976A (ja) | 2009-09-03 |
SG153774A1 (en) | 2009-07-29 |
CN101475560A (zh) | 2009-07-08 |
MA30619B1 (fr) | 2009-08-03 |
ZA200810841B (en) | 2009-12-30 |
US20090176794A1 (en) | 2009-07-09 |
FR2926077A1 (fr) | 2009-07-10 |
NZ573976A (en) | 2010-05-28 |
AU2009200010A1 (en) | 2009-07-23 |
EP2078716A1 (fr) | 2009-07-15 |
KR20090075632A (ko) | 2009-07-08 |
EA200802427A1 (ru) | 2009-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112018071093A2 (pt) | composto de fórmula, composição farmacêutica, e método para prevenir ou tratar um distúrbio sanguíneo | |
MX2009011208A (es) | Derivados de acido nicotinico como moduladores del receptor de glutamato metabotropico-5. | |
NO20064160L (no) | Nye azaibicykliske forbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem | |
ME00680B (me) | Nova jedinjenja diozmetina, postupak za njihovo dobijanje i farmaceutske kompozicije koje ih sadrže | |
BRPI0507903A (pt) | derivados de quinazolina e composição farmacêutica compreendendo os mesmos | |
TR200400859T4 (tr) | Yeni heterosiklik bileşikler, özellikle antibakteriyel preparatları. | |
BR112014009717A2 (pt) | "derivados de 2-(fenil ou pirid-3-il)aminopirimidina, seus usos, e composição farmacêutica" | |
BRPI0911035A2 (pt) | ativadores de pirrolidinona glicoquinase | |
BRPI0415759A (pt) | compostos de pirimidin-4-il-3,4-tiona e uso dos mesmos na terapia | |
BR112013001632A2 (pt) | composto, composição farmacêutica, método de inibir uma atividade uma jak quinase in vitro, uso de um composto, ou da composição farmacêutica, e, método de fabricar um composto | |
UY29510A1 (es) | Derivados de urea, metodos para su fabricación, y usos de los mismos | |
BRPI0804091B8 (pt) | compostos de 1,2,4,5-tetrahidro-3h-benzazepina, processo para sua preparação e composições farmacêuticas que os contêm | |
BR112015008717A2 (pt) | composto, composição farmacêutica, método de tratar diabetes do tipo ii, uso do composto de fórmula (i), medicação para o tratamento de diabetes do tipo ii | |
BRPI0720742B8 (pt) | derivados de heteroaril pirrolidinil e piperidinil cetona, seus usos e composição farmacêutica compreendo os mesmos | |
WO2009012375A3 (en) | Squarate kinase inhibitors | |
EA200600760A1 (ru) | Новые соединения фенилпиридилпиперазина, способ их получения и фармацевтические композиции, содержащие их | |
DK1970372T3 (da) | Salte af 9-oxoacridin-10-eddikesyre med 1-alkylamino-1-deoxy-polyoler | |
SG165381A1 (en) | Novel benzimidazole and benzothiazole derivatives, method for preparing same, use thereof as drugs, pharmaceutical compositions and novel use in particular as c-met inhibitors | |
BRPI0411308A (pt) | composto, composição farmacêutica, processo para a preparação de um composto, e, uso de um composto | |
BR112014031969A2 (pt) | derivados de pirimidinona como agentes antimaláricos | |
BRPI0900030A2 (pt) | compostos de 1h-indol-1-il-uréia, um processo para sua preparação e composições farmacêuticas contendo-os | |
CY1112979T1 (el) | Διαδικασια για την παρασκευη της ενωσης (s)-1-αλκυλ-2',6'-πιπεκολοξυλιδιδιου | |
BRPI0507511A (pt) | composto, uso de um composto, composição farmacêutica,e, processo para preparar um composto | |
BR112016009918A2 (pt) | composto tendo maior inibição da atividade da proteína cinase g e método de preparação para tal | |
BRPI1001935A2 (pt) | Compostos de ácido 2-mercaptociclopentanocarboxílico, um processo para sua preparação e composições farmacêuticas contendo-os |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B03A | Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette] | ||
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 3A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: NAO APRESENTADA A GUIA DE CUMPRIMENTO DE EXIGENCIA. REFERENTE A 3A ANUIDADE. |